Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE).

William CamuPhilippe LehertCharles Pierrot-DeseillignyPatrick HautecoeurAnne BesserveAnne-Sophie Jean DelegliseMarianne PayetEric ThouvenotJean Claude Souberbielle

Published in: Neurology(R) neuroimmunology & neuroinflammation (2019)

This study provides Class II evidence that for patients with RRMS and low serum 25OHD, cholecalciferol did not significantly affect ARRs.

Keyphrases

multiple sclerosis
disease activity
mass spectrometry
ms ms
rheumatoid arthritis